CRISPR Therapeutics AG (CRSP)
1 Item 5.02 filing since 2026-10-19 · roles: CFO. Nasdaq. Biological Products, (No Diagnostic Substances).
| Score | Filed | Event | Role | Person | Seat | Summary |
|---|---|---|---|---|---|---|
| 60 | 2026-10-19 | Appointment | CFO | subscribers | — | CRISPR Therapeutics AG (CRSP): CFO Andrew J. Silver appointed |
Executive changes at other companies: all filings · CEO · CFO · How Item 5.02 works